Tina Singh, Md

Senior Safety Physician, SERM BE
GSK, Belgium

Abstracts(s):

• PC1238: Similar Low Rate of Febrile Convulsions and Comparable Safety Data Reported for Gsk’s Measles-mumps-rubella (MMR) Vaccine versus Merck’s MMR Vaccine in Clinical Trials
  Saturday, October 8, 2022

  2:15 PM – 3:15 PM US PDT